Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 3/20 | 0.51 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.46 |
| ▸ | GGH | Q92820 | 2/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.42 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | ECE1 | P42892 | 2/20 | 0.37 |
| ▸ | CPA1 | P15085 | 1/20 | 0.36 |
| ▸ | CPA2 | P48052 | 1/20 | 0.36 |
| ▸ | CPA4 | Q9UI42 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL418690 | 1.00 | FOLH1 (0.51) | FOLH1GSRRNPEPGGHMMP2 | |
| Hydrochloric Acid SCHEMBL31662922 | 0.98 | FOLH1 (0.50) | FOLH1GSRRNPEPGGHMMP2 | |
| SCHEMBL30701108 | 0.82 | FOLH1 (0.50) | FOLH1GSRRNPEPGGHMMP2 | |
| Phosphoric Acid SCHEMBL11671675 | 0.80 | FOLH1 (0.50) | FOLH1GSRRNPEPMMP2MMP9 | |
| Phosphoric Acid SCHEMBL11671672 | 0.80 | FOLH1 (0.50) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL2987576 | 0.79 | FOLH1 (0.49) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL11672835 | 0.79 | FOLH1 (0.49) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL2987580 | 0.79 | FOLH1 (0.49) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL11672840 | 0.79 | FOLH1 (0.49) | FOLH1GSRRNPEPMMP2MMP9 | |
| SCHEMBL11670979 | 0.79 | FOLH1 (0.49) | FOLH1GSRRNPEPMMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120154752-A | Gradient cured calcium silicate and calcium phosphate bone tissue filling and repairing material | 重庆九心医疗科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-119735180-A | Hydroxyapatite microsphere and preparation method thereof | 北京纳通医学研究院有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-118356523-A | Solid phase composition of bone adhesive for oral cavity, preparation method thereof and bone adhesive | 北京纳通医学科技研究院有限公司 | 2024-07-19 | — | — | CN | claimed |
| CN-117860951-A | Bone tissue adhesive for non-load-bearing part and preparation method thereof | 北京大学口腔医学院 | 2024-04-12 | — | — | CN | claimed |
| CN-114345919-B | Method for leaching and repairing arsenic-polluted soil by amino acid ionic liquid | 江南大学 | 2022-10-11 | — | — | CN | claimed |
| CN-114788888-A | Bone glue capable of being rapidly degraded in vivo and preparation method thereof | 苏州九心医疗科技有限公司 | 2022-07-26 | — | — | CN | claimed |
| US-20150159214-A1 | DEP2 AND ITS USES IN MAJOR DEPRESSIVE DISORDER AND OTHER RELATED DISORDERS | ABBVIE INC (US) | 2015-06-11 | — | — | US | claimed |
| EP-2024381-A2 | DEP2 AND ITS USES IN MAJOR DEPRESSIVE DISORDER AND OTHER RELATED DISORDERS | Abbott Laboratories (US) | 2009-02-18 | — | — | EP | claimed |
| WO-2007127830-A2 | DEP2 AND ITS USES IN MAJOR DEPRESSIVE DISORDER AND OTHER RELATED DISORDERS | ABBOTT LABORATORIES (US) | 2007-11-08 | — | — | WO | claimed |
| US-20070256149-A1 | Dep2 and its uses in major depressive disorder and other related disorders | MYRIAD GENETICS, INC. | 2007-11-01 | — | — | US | claimed |
| US-20070256148-A1 | DEP2 and its uses in major depressive disorder and other related disorders | ABBOTT LABORATORIES | 2007-11-01 | — | — | US | claimed |
| EP-0651652-B1 | TREATMENT FOR SENSITIVE TEETH | UNIV MELBOURNE (AU) | 2000-02-09 | — | — | EP | claimed |
| US-5981475-A | DENTINAL HYPERSENSITIVITY REDUCING AGENT CONTAINING A CASEIN, A COMPONENT OF CASEIN, A PHOSPHOPROTEIN AND A PHOSPHOPEPTIDE, COMPRISING AMINO ACYL RESIDUES OF PHOSPHOSERIN, PHOSPHOLYSIN,POHSOPHOTHREONINE, PHOSPHOTYROSINE, | THE UNIVERSITY OF MELBOURNE (AU) | 1999-11-09 | — | — | US | claimed |
| EP-0651652-A4 | TREATMENT FOR SENSITIVE TEETH. | UNIV MELBOURNE (AU) | 1996-10-23 | — | — | EP | claimed |
| EP-0651652-A1 | TREATMENT FOR SENSITIVE TEETH | THE UNIVERSITY OF MELBOURNE (AU) | 1995-05-10 | — | — | EP | claimed |
| WO-1994000146-A1 | TREATMENT FOR SENSITIVE TEETH | THE UNIVERSITY OF MELBOURNE (AU) | 1994-01-06 | — | — | WO | claimed |
| US-20260132466-A1 | METHODS AND SYSTEMS FOR PROCESSING A NUCLEIC ACID SAMPLE | DUKE UNIV (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260091025-A1 | BIOMOLECULES INVOLVED IN ALZHEIMER'S DISEASE | ELECTROPHORETICS LIMITED (GB) | 2026-04-02 | — | — | US | disclosed |
| EP-0651652-B1 | TREATMENT FOR SENSITIVE TEETH | UNIV MELBOURNE (AU) | 2000-02-09 | — | — | EP | disclosed |
| US-5981475-A | DENTINAL HYPERSENSITIVITY REDUCING AGENT CONTAINING A CASEIN, A COMPONENT OF CASEIN, A PHOSPHOPROTEIN AND A PHOSPHOPEPTIDE, COMPRISING AMINO ACYL RESIDUES OF PHOSPHOSERIN, PHOSPHOLYSIN,POHSOPHOTHREONINE, PHOSPHOTYROSINE, | THE UNIVERSITY OF MELBOURNE (AU) | 1999-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091025-A1 | BIOMOLECULES INVOLVED IN ALZHEIMER'S DISEASE | PYGB, PACSIN2, PPP3CA | FOLH1 1351/4885GSR 3643/4885RNPEP 604/4885 |
| US-20260132466-A1 | METHODS AND SYSTEMS FOR PROCESSING A NUCLEIC ACID SAMPLE | SPOUT1, NOP2, POLI | FOLH1 1872/4885GSR 4758/4885RNPEP 720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.